1.科研項目(主持) (1)山西省優青項目(202303021224012):202401-202612,25萬,在研 (2)國家自然科學基金面上項目(82271761):202301-202612,55萬,在研 (3)中國博士后基金面上項目(2022M722008):202301-202412,8萬,在研 (4)國家自然科學基金青年項目(82001656):202101-202312,24萬,結題 (5)山西白求恩醫院科研啟動項目(2021RC009):202107-202506,20萬,在研 (6)山西白求恩醫院國自然“種子選手”培育項目:10萬,在研 (7)山西省博士后項目:202301-202412,16萬,在研 2.學術論文 (1) SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism, Signal Transduction and Targeted Therapy,2021(共一第一,IF=38.1, TOP1區) (2) STING couples with PI3K to regulate actin reorganization during BCR activation, Science Advances, 2020(共一第一,IF=13.1, TOP1區) (3) Dedicator of cytokinesis protein 2 couples with lymphoid enhancer-binding factor 1 to regulate expression of CD21 and B-cell differentiation, Journal of Allergy and Clinical Immunology, 2019(共一第一,IF=14.1, TOP1區) (4) DOCK2 couples with LEF-1 to regulate B cell metabolism and memory response, Biochemical and Biophysical Research Communications, 2020(共一第二,IF=2.7) (5)A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection,Applied microbiology and biotechnology; 2015(共一第三,IF=3.6) (6) Expression of USP25 associates with fibrosis, inflammation and metabolism changes in IgG4-related disease, Nature Communication; 2024(第二作者,IF=16.6) 3. 學術任職:山西省檢驗醫師學會青年委員會副主任委員 |